Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ensysce Biosciences (ENSC) Asset Utilization Ratio (2020 - 2025)

Historic Asset Utilization Ratio for Ensysce Biosciences (ENSC) over the last 6 years, with Q3 2025 value amounting to 1.03.

  • Ensysce Biosciences' Asset Utilization Ratio rose 4123.65% to 1.03 in Q3 2025 from the same period last year, while for Sep 2025 it was 1.03, marking a year-over-year increase of 4123.65%. This contributed to the annual value of 1.25 for FY2024, which is 14167.39% up from last year.
  • As of Q3 2025, Ensysce Biosciences' Asset Utilization Ratio stood at 1.03, which was up 4123.65% from 1.46 recorded in Q2 2025.
  • In the past 5 years, Ensysce Biosciences' Asset Utilization Ratio ranged from a high of 1.46 in Q2 2025 and a low of 0.24 during Q3 2021
  • For the 5-year period, Ensysce Biosciences' Asset Utilization Ratio averaged around 0.64, with its median value being 0.55 (2023).
  • Per our database at Business Quant, Ensysce Biosciences' Asset Utilization Ratio crashed by 3994.07% in 2021 and then soared by 11140.93% in 2023.
  • Over the past 5 years, Ensysce Biosciences' Asset Utilization Ratio (Quarter) stood at 0.27 in 2021, then soared by 31.75% to 0.36 in 2022, then surged by 111.41% to 0.75 in 2023, then decreased by 7.6% to 0.7 in 2024, then surged by 47.43% to 1.03 in 2025.
  • Its last three reported values are 1.03 in Q3 2025, 1.46 for Q2 2025, and 1.22 during Q1 2025.